PF-07817883 Tablet

C5091017 - AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS

C5091018 - An Interventional Efficacy And Safety, Phase 3, Randomized, Double-Blind, 3-Arm Study To Investigate Ibuzatrelvir in Adults With Symptomatic COVID-19 Who Are Severely Immunocompromised